AGP Executive Report
Last update: 11 hours agoHealth Diplomacy: Gilead renewed a five-year WHO partnership to speed access to kala-azar (visceral leishmaniasis) care, pledging $9.2m and donating 400,000+ vials of AmBisome, with expanded focus across East Africa including Djibouti. Climate Risk: IGAD’s GHACOF warns June–September rains will likely be below normal across much of the northern Greater Horn—Djibouti, Ethiopia, Eritrea, Sudan and parts of Kenya—raising food and water stress. Regional Security & Governance: Kenya’s Court of Appeal lifted a block on a $1.6b Kenya–US medical cooperation deal, even as concerns remain over data protection and constitutional compliance; meanwhile, MSF says South Sudan is blocking humanitarian access to opposition areas. Energy & Trade: Djibouti has started building a $160m Fuelstor fuel and logistics terminal in Damerjog, aiming to store and redistribute fuel, LPG and edible oil for inland East Africa. Biodiversity & Public Health: A WHO-led study says climate disruption is increasing human contact with venomous snakes, boosting bite risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/179f22ed1a6a3c1d57925a4827178fc8a26ce057-1280x720.png)
